Indrapr.Medical

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE681B01017
  • NSEID: INDRAMEDCO
  • BSEID: 532150
INR
362.55
1.9 (0.53%)
BSENSE

Nov 20

BSE+NSE Vol: 2.32 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2026 is 8.35% vs 8.92% in Sep 2025

stock-summary

Standalone Net Profit

YoY Growth in quarter ended Sep 2026 is 8.33% vs 16.65% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2026 is 8.60% vs 12.05% in Sep 2025

stock-summary

Interest

YoY Growth in quarter ended Sep 2026 is 9.93% vs -5.03% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025

Compare Quarterly Results Of Indrapr.Medical With
Markets Mojo
Figures in Cr
Standalone Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
412.85
235.13
177.72
75.58%
Other Operating Income
0.00
0.00
0.00
Total Operating income
412.85
235.13
177.72
75.58%
Raw Material Cost
67.42
0.00
67.42
Purchase of Finished goods
0.00
37.97
-37.97
-100.00%
(Increase) / Decrease In Stocks
0.00
-10.03
10.03
100.00%
Employee Cost
78.53
48.27
30.26
62.69%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
111.53
0.00
111.53
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
77.93
86.89
-8.96
-10.31%
Total Expenditure (Excl Depreciation)
335.41
163.10
172.31
105.65%
Operating Profit (PBDIT) excl Other Income
77.44
72.03
5.41
7.51%
Other Income
8.55
-2.31
10.86
470.13%
Operating Profit (PBDIT)
85.99
69.72
16.27
23.34%
Interest
1.66
4.04
-2.38
-58.91%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
84.33
65.68
18.65
28.40%
Depreciation
12.26
16.43
-4.17
-25.38%
Profit Before Tax
72.07
49.24
22.83
46.36%
Tax
18.49
12.90
5.59
43.33%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
53.58
36.34
17.24
47.44%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
53.58
36.34
17.24
47.44%
Equity Capital
91.67
24.86
66.81
268.74%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.84
2.92
2.92
100.00%
Diluted Earnings per share
5.84
2.92
2.92
100.00%
Operating Profit Margin (Excl OI)
18.76%
30.63%
0.00
-11.87%
Gross Profit Margin
20.43%
27.93%
0.00
-7.50%
PAT Margin
12.98%
15.46%
0.00
-2.48%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 412.85 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 1.65% vs 11.33% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 8.35% vs 8.92% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 53.58 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -4.06% vs 33.93% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 8.33% vs 16.65% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 77.44 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -2.97% vs 31.90% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 8.60% vs 12.05% in Sep 2025

Quarterly - Interest
Interest 1.66 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 0.61% vs 10.74% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 9.93% vs -5.03% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.76%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025